Cargando…

Isoagglutinin reduction in intravenous immunoglobulin (IgPro10, Privigen) by specific immunoaffinity chromatography reduces its reporting rates of hemolytic reactions: an analysis of spontaneous adverse event reports

BACKGROUND: Hemolysis is an infrequent but recognized and potentially serious adverse effect of intravenous immunoglobulin (IVIG). Relatively elevated hemolysis reporting rates were seen with some IVIG products with high anti‐A/B isoagglutinin content, among which IgPro10 (Privigen, CSL Behring). Fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shebl, Amgad, Gabriel, Susie, Van Dinther, Kristy, Hubsch, Alphonse, Lawo, John‐Philip, Hoefferer, Liane, Welsh, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Blood Components
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383922/ https://www.ncbi.nlm.nih.gov/pubmed/32410287 http://dx.doi.org/10.1111/trf.15846

Ejemplares similares

Anti‐A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital‐based cohort study
por: Wallenhorst, Christopher, et al.
Publicado: (2020)

Incidence and risk factors for intravenous immunoglobulin‐related hemolysis: A systematic review of clinical trial and real‐world populations
por: Cuesta, Hillary, et al.
Publicado: (2022)

The quality of stored umbilical cord and adult-donated whole blood in Mombasa, Kenya
por: Hassall, Oliver, et al.
Publicado: (2010)

Biochemical comparison of four commercially available C1 esterase inhibitor concentrates for treatment of hereditary angioedema
por: Feussner, Annette, et al.
Publicado: (2014)

Pathogen reduction of double‐dose platelet concentrates from pools of eight buffy coats: Product quality, safety, and economic aspects
por: Rosskopf, Konrad, et al.
Publicado: (2020)

The use of cryopreserved platelets in a trauma‐induced hemorrhage model
por: Kleinveld, Derek J.B., et al.
Publicado: (2020)

Prolonged (post‐thaw) shelf life of −80°C frozen AB apheresis plasma
por: Rijnhout, Tim W.H., et al.
Publicado: (2020)

Inactivation of Plasmodium falciparum in whole blood using the amustaline and glutathione pathogen reduction technology
por: Sow, Cissé, et al.
Publicado: (2020)

Impact of cold storage on platelets treated with Intercept pathogen inactivation
por: Six, Katrijn R., et al.
Publicado: (2019)

Evaluation of riboflavin photochemical treatment for inactivation of HCT116 tumor cells mixed in simulative intraoperative salvage blood
por: Yu, Yang, et al.
Publicado: (2019)

Biotinylation of platelets for transfusion purposes a novel method to label platelets in a closed system
por: de Bruin, Sanne, et al.
Publicado: (2019)

The senotherapeutic nicotinamide riboside raises platelet nicotinamide adenine dinucleotide levels but cannot prevent storage lesion
por: Delabie, Willem, et al.
Publicado: (2019)

The use of a hematology analyzer with a new generation of software as an alternative to flow cytometry for enumerating residual white blood cells in blood components
por: Blanco, Richard Alejo, et al.
Publicado: (2019)

Preclinical safety assessment of pathogen reduced red blood cells treated with amustaline and glutathione
por: North, Anne K., et al.
Publicado: (2020)

Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen‐reduction technology
por: Girard, Yvette A., et al.
Publicado: (2020)

Effective inactivation of a wide range of viruses by pasteurization
por: Gröner, Albrecht, et al.
Publicado: (2017)

Residual red cells in blood components: A multisite study of fully automated enumeration using a hematology analyzer
por: Cavagnetto, Chloe, et al.
Publicado: (2020)

Cryopreservation of buffy coat derived platelets: Paired in vitro characterization using uncontrolled versus controlled freezing rate protocols
por: Tynngård, Nahreen, et al.
Publicado: (2020)

Nanofiltration as a robust method contributing to viral safety of plasma‐derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers
por: Roth, Nathan J., et al.
Publicado: (2020)

Surrogate test performance for SARS‐CoV‐2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): How useful could they be?
por: Wendel, Silvano, et al.
Publicado: (2021)

Evaluation of amotosalen and UVA pathogen‐reduced apheresis platelets after 7‐day storage
por: Cancelas, Jose A., et al.
Publicado: (2022)

Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction
por: Sow, Cissé, et al.
Publicado: (2022)

Characterization and first‐in‐human clinical dose‐escalation safety evaluation of a next‐gen human freeze‐dried plasma
por: Cancelas, Jose A., et al.
Publicado: (2021)

Frozen and freeze‐dried solvent/detergent treated plasma: Two different pharmaceutical formulations with comparable quality
por: Heger, Andrea, et al.
Publicado: (2022)

Frozen for combat: Quality of deep‐frozen thrombocytes, produced and used by The Netherlands Armed Forces 2001–2021
por: Noorman, Femke, et al.
Publicado: (2022)

Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment
por: Gerber, Simon, et al.
Publicado: (2016)

Associations of blood pressure components with risks of cardiovascular events and all‐cause death in a Chinese population: A Prospective Study
por: Zhang, Zhongying, et al.
Publicado: (2022)

Clinical Experience With an L-Proline–Stabilized 10 % Intravenous Immunoglobulin (Privigen®): Real-Life Effectiveness and Tolerability
por: Dorsey, Morna J., et al.
Publicado: (2014)

Impact of screening and exclusion of high anti‐A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: A hospital‐based cohort study in the US
por: Martinez, Carlos, et al.
Publicado: (2017)

Specific protein content of pools of plasma for fractionation from different sources: impact of frequency of donations
por: Laub, R, et al.
Publicado: (2010)

In vitro and in vivo properties differ among liquid intravenous immunoglobulin preparations
por: Dhainaut, F, et al.
Publicado: (2013)

Defining and measuring blood donor altruism: a theoretical approach from biology, economics and psychology
por: Evans, R, et al.
Publicado: (2014)

Prospective multicentre study of the effect of voluntary plasmapheresis on plasma cholesterol levels in donors
por: Rosa-Bray, M, et al.
Publicado: (2013)

The effect of plasmapheresis on blood pressure in voluntary plasma donors
por: Rosa-Bray, M, et al.
Publicado: (2015)

Perspectives on the impact of storage duration on blood quality and transfusion outcomes
por: Roback, J. D.
Publicado: (2016)

Platelet responses to agonists in a cohort of highly characterised platelet donors are consistent over time
por: Garner, S. F., et al.
Publicado: (2016)

Donor InSight: characteristics and representativeness of a Dutch cohort study on blood and plasma donors
por: Timmer, Tiffany C., et al.
Publicado: (2018)

Red‐blood‐cell manufacturing methods and storage solutions differentially induce pulmonary cell activation
por: Wirtz, Mathijs R., et al.
Publicado: (2020)

The supply chain of migrant blood donors: an organisational interview study
por: Klinkenberg, Elisabeth F., et al.
Publicado: (2019)

A comparison of haematopoietic stem cells from umbilical cord blood and peripheral blood for platelet production in a microfluidic device
por: Six, Katrijn R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s85q4k7dlaft13ga74pg6dgs7f